☰

Matthew A Stern - Publications

Affiliations: 
Emory University, Atlanta, GA 
Area:
Epilepsy, Movement Disorders
Tree Info Grants Similar researchers PubMed Report error

12/58 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Stern MA, Cole ER, Gross RE, Berglund K. Seizure Event Detection Using Intravital Two-Photon Calcium Imaging Data. Biorxiv : the Preprint Server For Biology. PMID 37808822 DOI: 10.1101/2023.09.28.558338  0.317
2022 Stern MA, Skelton H, Fernandez AM, Gutekunst CN, Gross RE, Berglund K. Applications of Bioluminescence-Optogenetics in Rodent Models. Methods in Molecular Biology (Clifton, N.J.). 2525: 347-363. PMID 35836082 DOI: 10.1007/978-1-0716-2473-9_27  0.42
2022 Stern MA, Skelton H, Fernandez AM, Gutekunst CN, Berglund K, Gross RE. Bioluminescence-Optogenetics: A Practical Guide. Methods in Molecular Biology (Clifton, N.J.). 2525: 333-346. PMID 35836081 DOI: 10.1007/978-1-0716-2473-9_26  0.43
2021 William CM, Stern MA, Pei X, Saqran L, Ramani M, Frosch MP, Hyman BT. Impairment of visual cortical plasticity by amyloid-beta species. Neurobiology of Disease. 154: 105344. PMID 33766652 DOI: 10.1016/j.nbd.2021.105344  0.549
2021 Berglund K, Stern MA, Gross RE. Bioluminescence-Optogenetics. Advances in Experimental Medicine and Biology. 1293: 281-293. PMID 33398820 DOI: 10.1007/978-981-15-8763-4_17  0.402
2020 Stern MA, Isbaine F, Qiu D, Riley JP, Boulis NM, Gross RE. Radiofrequency ablation through previously effective deep brain stimulation leads for Parkinson's disease: A retrospective series. World Neurosurgery. PMID 32949803 DOI: 10.1016/J.Wneu.2020.09.060  0.446
2020 Stern MA, Malcolm JG, Willie JT, Gross RE, Drane DL. Letter: Magnetic Resonance Imaging-Guided Laser Interstitial Thermal Therapy for Epilepsy: Systematic Review of Technique, Indications, and Outcomes. Neurosurgery. PMID 32615597 DOI: 10.1093/Neuros/Nyaa274  0.491
2019 Willie JT, Malcolm JG, Stern MA, Lowder LO, Neill SG, Cabaniss BT, Drane DL, Gross RE. Safety and effectiveness of stereotactic laser ablation for epileptogenic cerebral cavernous malformations. Epilepsia. PMID 30653657 DOI: 10.1111/Epi.14634  0.494
2018 Gross RE, Stern MA. Magnetic resonance-guided stereotactic laser pallidotomy for dystonia. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 29701309 DOI: 10.1002/Mds.27400  0.475
2018 Gross RE, Stern MA, Willie JT, Fasano RE, Saindane AM, Soares BP, Pedersen NP, Drane DL. Stereotactic Laser Amygdalohippocampotomy for Mesial Temporal Lobe Epilepsy. Annals of Neurology. PMID 29420840 DOI: 10.1002/Ana.25180  0.478
2017 William CM, Saqran L, Stern MA, Chiang CL, Herrick S, Rangwala A, Albers MW, Frosch MP, Hyman BT. Activity-dependent dysfunction in visual and olfactory sensory systems in mouse models of Down syndrome. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 28899917 DOI: 10.1523/Jneurosci.1045-17.2017  0.563
2010 Langford DJ, Tuttle AH, Brown K, Deschenes S, Fischer DB, Mutso A, Root KC, Sotocinal SG, Stern MA, Mogil JS, Sternberg WF. Social approach to pain in laboratory mice. Social Neuroscience. 5: 163-70. PMID 19844845 DOI: 10.1080/17470910903216609  0.251
Low-probability matches (unlikely to be authored by this person)
2003 Siderowf A, Stern M. Update on Parkinson disease. Annals of Internal Medicine. 138: 651-8. PMID 12693888 DOI: 10.7326/0003-4819-138-8-200304150-00013  0.147
2005 Weaver F, Follett K, Hur K, Ippolito D, Stern M. Deep brain stimulation in Parkinson disease: a metaanalysis of patient outcomes. Journal of Neurosurgery. 103: 956-67. PMID 16381181 DOI: 10.3171/jns.2005.103.6.0956  0.135
2015 Rothlind JC, York MK, Carlson K, Luo P, Marks WJ, Weaver FM, Stern M, Follett K, Reda D. Neuropsychological changes following deep brain stimulation surgery for Parkinson's disease: comparisons of treatment at pallidal and subthalamic targets versus best medical therapy. Journal of Neurology, Neurosurgery, and Psychiatry. 86: 622-9. PMID 25185211 DOI: 10.1136/Jnnp-2014-308119  0.131
2013 Berg D, Lang AE, Postuma RB, Maetzler W, Deuschl G, Gasser T, Siderowf A, Schapira AH, Oertel W, Obeso JA, Olanow CW, Poewe W, Stern M. Changing the research criteria for the diagnosis of Parkinson's disease: obstacles and opportunities. The Lancet. Neurology. 12: 514-24. PMID 23582175 DOI: 10.1016/S1474-4422(13)70047-4  0.128
2011 Rascol O, Lozano A, Stern M, Poewe W. Milestones in Parkinson's disease therapeutics. Movement Disorders : Official Journal of the Movement Disorder Society. 26: 1072-82. PMID 21626552 DOI: 10.1002/Mds.23714  0.12
2010 Follett KA, Weaver FM, Stern M, Hur K, Harris CL, Luo P, Marks WJ, Rothlind J, Sagher O, Moy C, Pahwa R, Burchiel K, Hogarth P, Lai EC, Duda JE, et al. Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease. The New England Journal of Medicine. 362: 2077-91. PMID 20519680 DOI: 10.1056/Nejmoa0907083  0.118
2010 Marks WJ, Bartus RT, Siffert J, Davis CS, Lozano A, Boulis N, Vitek J, Stacy M, Turner D, Verhagen L, Bakay R, Watts R, Guthrie B, Jankovic J, Simpson R, ... Stern M, et al. Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial. The Lancet. Neurology. 9: 1164-72. PMID 20970382 DOI: 10.1016/S1474-4422(10)70254-4  0.114
2012 Weaver FM, Follett KA, Stern M, Luo P, Harris CL, Hur K, Marks WJ, Rothlind J, Sagher O, Moy C, Pahwa R, Burchiel K, Hogarth P, Lai EC, Duda JE, et al. Randomized trial of deep brain stimulation for Parkinson disease: thirty-six-month outcomes. Neurology. 79: 55-65. PMID 22722632 DOI: 10.1212/Wnl.0B013E31825Dcdc1  0.114
2009 Weaver FM, Follett K, Stern M, Hur K, Harris C, Marks WJ, Rothlind J, Sagher O, Reda D, Moy CS, Pahwa R, Burchiel K, Hogarth P, Lai EC, Duda JE, et al. Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. Jama. 301: 63-73. PMID 19126811 DOI: 10.1001/Jama.2008.929  0.113
2010 Stephenson R, Houghton D, Sundarararjan S, Doty RL, Stern M, Xie SX, Siderowf A. Odor identification deficits are associated with increased risk of neuropsychiatric complications in patients with Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 25: 2099-104. PMID 20669288 DOI: 10.1002/Mds.23234  0.109
2006 Siderowf A, Jaggi JL, Xie SX, Loveland-Jones C, Leng L, Hurtig H, Colcher A, Stern M, Chou KL, Liang G, Maccarone H, Simuni T, Baltuch G. Long-term effects of bilateral subthalamic nucleus stimulation on health-related quality of life in advanced Parkinson's disease. Movement Disorders. 21: 746-753. PMID 16463342 DOI: 10.1002/Mds.20786  0.104
2015 Warren Olanow C, Bartus RT, Baumann TL, Factor S, Boulis N, Stacy M, Turner DA, Marks W, Larson P, Starr PA, Jankovic J, Simpson R, Watts R, Guthrie B, Poston K, ... ... Stern M, et al. Gene delivery of neurturin to putamen and substantia nigra in Parkinson disease: A double-blind, randomized, controlled trial. Annals of Neurology. 78: 248-57. PMID 26061140 DOI: 10.1002/Ana.24436  0.102
2021 Rothlind JC, York MK, Luo P, Carlson K, Marks WJ, Weaver FM, Stern M, Follett KA, Duda JE, Reda DJ. Predictors of multi-domain cognitive decline following DBS for treatment of Parkinson's disease. Parkinsonism & Related Disorders. 95: 23-27. PMID 34974395 DOI: 10.1016/j.parkreldis.2021.12.011  0.101
2011 Halliday G, Lees A, Stern M. Milestones in Parkinson's disease--clinical and pathologic features. Movement Disorders : Official Journal of the Movement Disorder Society. 26: 1015-21. PMID 21626546 DOI: 10.1002/mds.23669  0.094
2013 Weintraub D, Duda JE, Carlson K, Luo P, Sagher O, Stern M, Follett KA, Reda D, Weaver FM. Suicide ideation and behaviours after STN and GPi DBS surgery for Parkinson's disease: results from a randomised, controlled trial. Journal of Neurology, Neurosurgery, and Psychiatry. 84: 1113-8. PMID 23667214 DOI: 10.1136/jnnp-2012-304396  0.088
2016 Postuma RB, Berg D, Adler CH, Bloem BR, Chan P, Deuschl G, Gasser T, Goetz CG, Halliday G, Joseph L, Lang AE, Liepelt-Scarfone I, Litvan I, Marek K, Oertel W, ... Stern M, et al. The new definition and diagnostic criteria of Parkinson's disease. The Lancet. Neurology. 15: 546-8. PMID 27302120 DOI: 10.1016/S1474-4422(16)00116-2  0.088
2021 Tropea TF, Amari N, Han N, Rick J, Suh E, Akhtar RS, Dahodwala N, Deik A, Gonzalez-Alegre P, Hurtig H, Siderowf A, Spindler M, Stern M, Thenganatt MA, Weintraub D, et al. Whole Clinic Research Enrollment in Parkinson's Disease: The Molecular Integration in Neurological Diagnosis (MIND) Study. Journal of Parkinson's Disease. PMID 33492247 DOI: 10.3233/JPD-202406  0.087
2017 Jennings D, Siderowf A, Stern M, Seibyl J, Eberly S, Oakes D, Marek K. Conversion to Parkinson Disease in the PARS Hyposmic and Dopamine Transporter-Deficit Prodromal Cohort. Jama Neurology. PMID 28595287 DOI: 10.1001/Jamaneurol.2017.0985  0.085
2010 Watts RL, Lyons KE, Pahwa R, Sethi K, Stern M, Hauser RA, Olanow W, Gray AM, Adams B, Earl NL. Onset of dyskinesia with adjunct ropinirole prolonged-release or additional levodopa in early Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 25: 858-66. PMID 20461803 DOI: 10.1002/mds.22890  0.085
2004 Liang L, Chinnathambi S, Stern M, Tomanek-Chalkley A, Manuel TD, Bickenbach JR. As epidermal stem cells age they do not substantially change their characteristics. The Journal of Investigative Dermatology. Symposium Proceedings / the Society For Investigative Dermatology, Inc. [and] European Society For Dermatological Research. 9: 229-37. PMID 15369218 DOI: 10.1111/J.1087-0024.2004.09309.X  0.085
2016 Hu J, Stern M, Gimenez LE, Wanka L, Zhu L, Rossi M, Meister J, Inoue A, Beck-Sickinger AG, Gurevich VV, Wess J. A G Protein-Biased Designer G Protein-Coupled Receptor Useful for Studying the Physiological Relevance of Gq/11-Dependent Signaling Pathways. The Journal of Biological Chemistry. PMID 26851281 DOI: 10.1074/Jbc.M115.702282  0.084
2014 Jennings D, Siderowf A, Stern M, Seibyl J, Eberly S, Oakes D, Marek K. Imaging prodromal Parkinson disease: the Parkinson Associated Risk Syndrome Study. Neurology. 83: 1739-46. PMID 25298306 DOI: 10.1212/Wnl.0000000000000960  0.083
2015 Berg D, Postuma RB, Adler CH, Bloem BR, Chan P, Dubois B, Gasser T, Goetz CG, Halliday G, Joseph L, Lang AE, Liepelt-Scarfone I, Litvan I, Marek K, Obeso J, ... ... Stern M, et al. MDS research criteria for prodromal Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 1600-11. PMID 26474317 DOI: 10.1002/Mds.26431  0.082
2006 Siderowf A, Stern M. Clinical trials with rasagiline: evidence for short-term and long-term effects. Neurology. 66: S80-8. PMID 16717255 DOI: 10.1212/WNL.66.10_SUPPL_4.S80  0.082
2016 Brennan L, Siderowf A, Rubright JD, Rick J, Dahodwala N, Duda JE, Hurtig H, Stern M, Xie SX, Rennert L, Karlawish J, Shea JA, Trojanowski JQ, Weintraub D. The Penn Parkinson's Daily Activities Questionnaire-15: Psychometric properties of a brief assessment of cognitive instrumental activities of daily living in Parkinson's disease. Parkinsonism & Related Disorders. PMID 26923524 DOI: 10.1016/J.Parkreldis.2016.02.020  0.08
2020 Siderowf A, Jennings D, Stern M, Seibyl J, Eberly S, Oakes D, Marek K. Clinical and Imaging Progression in the PARS Cohort: Long-Term Follow-up. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 32657461 DOI: 10.1002/Mds.28139  0.079
2005 Robinson K, Dennison A, Roalf D, Noorigian J, Cianci H, Bunting-Perry L, Moberg P, Kleiner-Fisman G, Martine R, Duda J, Jaggi J, Stern M. Falling risk factors in Parkinson's disease Neurorehabilitation. 20: 169-182. PMID 16340098 DOI: 10.3233/Nre-2005-20304  0.074
2006 deMarcaida JA, Schwid SR, White WB, Blindauer K, Fahn S, Kieburtz K, Stern M, Shoulson I. Effects of tyramine administration in Parkinson's disease patients treated with selective MAO-B inhibitor rasagiline. Movement Disorders : Official Journal of the Movement Disorder Society. 21: 1716-21. PMID 16856145 DOI: 10.1002/Mds.21048  0.074
2006 Blindauer K, Shoulson I, Oakes D, Kieburtz K, Schwid S, Fahn S, Stern M, Goetz C, Nutt J, Goren S, Sayag N, Scolnik M, Levy R, Eyal E, Salzman P, et al. A randomized controlled trial of etilevodopa in patients with Parkinson disease who have motor fluctuations. Archives of Neurology. 63: 210-6. PMID 16476809 DOI: 10.1001/Archneur.63.2.210  0.073
2014 Berg D, Postuma RB, Bloem B, Chan P, Dubois B, Gasser T, Goetz CG, Halliday GM, Hardy J, Lang AE, Litvan I, Marek K, Obeso J, Oertel W, Olanow CW, ... ... Stern M, et al. Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 454-62. PMID 24619848 DOI: 10.1002/Mds.25844  0.069
2015 Brennan L, Siderowf A, Rubright JD, Rick J, Dahodwala N, Duda JE, Hurtig H, Stern M, Xie SX, Rennert L, Karlawish J, Shea JA, Trojanowski JQ, Weintraub D. Development and initial testing of the Penn Parkinson's Daily Activities Questionnaire. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 26249849 DOI: 10.1002/Mds.26339  0.069
2002 Shults CW, Oakes D, Kieburtz K, Beal MF, Haas R, Plumb S, Juncos JL, Nutt J, Shoulson I, Carter J, Kompoliti K, Perlmutter JS, Reich S, Stern M, Watts RL, et al. Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline. Archives of Neurology. 59: 1541-50. PMID 12374491 DOI: 10.1001/Archneur.59.10.1541  0.066
2012 Dahodwala N, Karlawish J, Shea JA, Zubritsky C, Stern M, Mandell DS. Validation of an instrument to measure older adults' expectations regarding movement (ERM). Plos One. 7: e43854. PMID 22937110 DOI: 10.1371/journal.pone.0043854  0.065
2018 Berg D, Adler CH, Bloem BR, Chan P, Gasser T, Goetz CG, Halliday G, Lang AE, Lewis S, Li Y, Liepelt-Scarfone I, Litvan I, Marek K, Maetzler C, Mi T, ... Stern M, et al. Movement disorder society criteria for clinically established early Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 30145841 DOI: 10.1002/Mds.27431  0.065
2014 Papay K, Xie SX, Stern M, Hurtig H, Siderowf A, Duda JE, Minger J, Weintraub D. Naltrexone for impulse control disorders in Parkinson disease: a placebo-controlled study. Neurology. 83: 826-33. PMID 25037206 DOI: 10.1212/Wnl.0000000000000729  0.063
2005 Follett K, Weaver F, Stern M, Marks W, Hogarth P, Holloway K, Bronstein J, Duda J, Horn S, Lai E, Samii A, Okun MS, Foote KD. Multisite randomized trial of deep brain stimulation [4] (multiple letters) Archives of Neurology. 62: 1643-1645. PMID 16216957 DOI: 10.1001/archneur.62.10.1643-b  0.06
2020 Kreuzer M, Stern MA, Hight D, Berger S, Schneider G, Sleigh JW, García PS. Spectral and Entropic Features Are Altered by Age in the Electroencephalogram in Patients under Sevoflurane Anesthesia. Anesthesiology. PMID 32108685 DOI: 10.1097/Aln.0000000000003182  0.055
2015 Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Obeso J, Marek K, Litvan I, Lang AE, Halliday G, Goetz CG, Gasser T, Dubois B, Chan P, et al. MDS clinical diagnostic criteria for Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 1591-601. PMID 26474316 DOI: 10.1002/Mds.26424  0.055
2006 Biglan KM, Schwid S, Eberly S, Blindauer K, Fahn S, Goren T, Kieburtz K, Oakes D, Plumb S, Siderowf A, Stern M, Shoulson I. Rasagiline improves quality of life in patients with early Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 21: 616-23. PMID 16450340 DOI: 10.1002/Mds.20764  0.053
2021 Kostelnik C, Hohn J, Escoto-Diaz CE, Kooistra JB, Stern M, Swinton DE, Richardson W, Carver W, Eberth J. Small-diameter artery decellularization: Effects of anionic detergent concentration and treatment duration on porcine internal thoracic arteries. Journal of Biomedical Materials Research. Part B, Applied Biomaterials. PMID 34855280 DOI: 10.1002/jbm.b.34969  0.05
2023 Shin J, Andrews M, DeJean L, Debski N, Exarchakis A, Fleming J, Gandhi R, Hum C, Kalladanthyil A, Maddigunta R, Napoli L, Nguyen C, Paul R, Schmalbach N, Sichel J, ... ... Stern M, et al. Risk Factors Associated With Atrial Fibrillation in Elderly Patients. Journal of Clinical Medicine Research. 15: 148-160. PMID 37035851 DOI: 10.14740/jocmr4884  0.049
2017 Fullard ME, Xie SX, Marek K, Stern M, Jennings D, Siderowf A, Willis AW, Chen-Plotkin AS. Vitamin D in the Parkinson Associated Risk Syndrome (PARS) study. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 28906025 DOI: 10.1002/Mds.27127  0.043
2009 Dahodwala N, Siderowf A, Xie M, Noll E, Stern M, Mandell DS. Racial differences in the diagnosis of Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 24: 1200-5. PMID 19412929 DOI: 10.1002/mds.22557  0.043
2016 Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Marek K, Litvan I, Lang AE, Halliday G, Goetz CG, Gasser T, Dubois B, Chan P, Bloem BR, et al. Abolishing the 1-year rule: How much evidence will be enough? Movement Disorders : Official Journal of the Movement Disorder Society. PMID 27666574 DOI: 10.1002/Mds.26796  0.035
2018 Stern MA, Stern J, Dengler WC. The importance of standardizing testing of refractory esophageal disorders with EGD, pH testing, and high resolution manometry with impedance Neurogastroenterology & Motility. 30: e13343. DOI: 10.1111/nmo.13343  0.025
2015 Jennings D, Siderowf A, Stern M, Seibyl J, Eberly S, Oakes D, Marek K. Author Response. Neurology. 84: 2292. PMID 26230002  0.015
Hide low-probability matches.